Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

0
Player Avatar speedracer0 (< 20) Submitted: 4/28/2011 4:42:24 PM : Outperform Start Price: $34.37 MRK Score: +12.22

At least 20 new drugs waiting last stage approval.

Featured Broker Partners


Advertisement